Clinical trial
Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
NCT00447070 · Foundation for Cardiovascular Research, Zurich, Other · Completed
Key facts
| NCT number | NCT00447070 |
|---|---|
| Title | Effect of Atazanavir on Endothelial Function in HIV-Infected Patients |
| Official title | Effect of Atazanavir on Endothelial Function in HIV-Infected Patients Compared to Standard Proteinase Inhibitors on Top of Potent Antiviral Combination Therapy |
| Acronym | ENDOPACT |
| Lead sponsor | Foundation for Cardiovascular Research, Zurich, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Dyslipidemia |
| Intervention type | Drug |
| Interventions | ATAZANAVIR |
| Enrollment | 50 |
| Start date | Aug 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Mar 14, 2007 |
| Last update posted | May 27, 2009 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: